Federal · Amendment
Benzodiazepines and Other Targeted Substances Regulations repealed in full
Benzodiazepines and Other Targeted Substances Regulations — under the CONTROLLED DRUGS AND SUBSTANCES ACT
Recorded date: October 1, 2026
Detected: November 17, 2026. Verify commencement in the official source.
Plain-language summary · AI-assisted
The entire Benzodiazepines and Other Targeted Substances Regulations have been repealed. All detailed rules previously contained in this instrument — covering possession, test kits, dealer licences, import/export permits, pharmacist and practitioner obligations, hospital requirements, security, record-keeping, advertising, and the scheduled substance lists — are no longer in force under this regulation. Anyone who was relying on this regulation for authorizations, compliance obligations, or operational guidance should identify what framework, if any, now governs those activities. Licensed dealers, pharmacists, practitioners, and hospitals that handled benzodiazepines and other targeted substances under this regulation should seek updated guidance on their obligations.
Who this affects
licensed dealers of targeted substances · pharmacists · physicians and other practitioners · hospital administrators · importers and exporters of benzodiazepines
Check the official text
SOR/2000-217 on the official source ↗
This page isn't an official version of the law and isn't legal advice. Summaries may omit details. Verify the dates and provisions that apply to you against the official source.